179 related articles for article (PubMed ID: 24633563)
1. Quantitative monitoring of tamoxifen in human plasma extended to 40 metabolites using liquid-chromatography high-resolution mass spectrometry: new investigation capabilities for clinical pharmacology.
Dahmane E; Boccard J; Csajka C; Rudaz S; Décosterd L; Genin E; Duretz B; Bromirski M; Zaman K; Testa B; Rochat B
Anal Bioanal Chem; 2014 Apr; 406(11):2627-40. PubMed ID: 24633563
[TBL] [Abstract][Full Text] [Related]
2. An ultra performance liquid chromatography-tandem MS assay for tamoxifen metabolites profiling in plasma: first evidence of 4'-hydroxylated metabolites in breast cancer patients.
Dahmane E; Mercier T; Zanolari B; Cruchon S; Guignard N; Buclin T; Leyvraz S; Zaman K; Csajka C; Decosterd LA
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Dec; 878(32):3402-14. PubMed ID: 21094101
[TBL] [Abstract][Full Text] [Related]
3. Tamoxifen metabolite isomer separation and quantification by liquid chromatography-tandem mass spectrometry.
Jaremko M; Kasai Y; Barginear MF; Raptis G; Desnick RJ; Yu C
Anal Chem; 2010 Dec; 82(24):10186-93. PubMed ID: 21086978
[TBL] [Abstract][Full Text] [Related]
4. Fast method for simultaneous quantification of tamoxifen and metabolites in dried blood spots using an entry level LC-MS/MS system.
Tré-Hardy M; Capron A; Antunes MV; Linden R; Wallemacq P
Clin Biochem; 2016 Nov; 49(16-17):1295-1298. PubMed ID: 27498307
[TBL] [Abstract][Full Text] [Related]
5. Identification of drug metabolites in human plasma or serum integrating metabolite prediction, LC-HRMS and untargeted data processing.
Jacobs PL; Ridder L; Ruijken M; Rosing H; Jager NG; Beijnen JH; Bas RR; van Dongen WD
Bioanalysis; 2013 Sep; 5(17):2115-28. PubMed ID: 23962251
[TBL] [Abstract][Full Text] [Related]
6. Analysis of phase I and phase II metabolites of tamoxifen in breast cancer patients.
Poon GK; Chui YC; McCague R; Lłnning PE; Feng R; Rowlands MG; Jarman M
Drug Metab Dispos; 1993; 21(6):1119-24. PubMed ID: 7905393
[TBL] [Abstract][Full Text] [Related]
7. Development of a high-performance liquid chromatography method with fluorescence detection for the routine quantification of tamoxifen, endoxifen and 4-hydroxytamoxifen in plasma from breast cancer patients.
Rangel-Méndez JA; Graniel-Sabido MJ; Sánchez-Cruz JF; Moo-Puc R
Biomed Chromatogr; 2019 Apr; 33(4):e4462. PubMed ID: 30536934
[TBL] [Abstract][Full Text] [Related]
8. Impacts of the Glucuronidase Genotypes UGT1A4, UGT2B7, UGT2B15 and UGT2B17 on Tamoxifen Metabolism in Breast Cancer Patients.
Romero-Lorca A; Novillo A; Gaibar M; Bandrés F; Fernández-Santander A
PLoS One; 2015; 10(7):e0132269. PubMed ID: 26176234
[TBL] [Abstract][Full Text] [Related]
9. Investigational study of tamoxifen phase I metabolites using chromatographic and spectroscopic analytical techniques.
Teunissen SF; Rosing H; Seoane MD; Brunsveld L; Schellens JH; Schinkel AH; Beijnen JH
J Pharm Biomed Anal; 2011 Jun; 55(3):518-26. PubMed ID: 21392921
[TBL] [Abstract][Full Text] [Related]
10. Imatinib metabolite profiling in parallel to imatinib quantification in plasma of treated patients using liquid chromatography-mass spectrometry.
Rochat B; Fayet A; Widmer N; Lahrichi SL; Pesse B; Décosterd LA; Biollaz J
J Mass Spectrom; 2008 Jun; 43(6):736-52. PubMed ID: 18286663
[TBL] [Abstract][Full Text] [Related]
11. Identification and quantification of tamoxifen and four metabolites in serum by liquid chromatography-tandem mass spectrometry.
Gjerde J; Kisanga ER; Hauglid M; Holm PI; Mellgren G; Lien EA
J Chromatogr A; 2005 Jul; 1082(1):6-14. PubMed ID: 16038189
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic drug monitoring of tamoxifen using LC-MS/MS.
Tchu SM; Lynch KL; Wu AH
Methods Mol Biol; 2012; 902():211-22. PubMed ID: 22767121
[TBL] [Abstract][Full Text] [Related]
13. Concentrations of tamoxifen and its major metabolites in hormone responsive and resistant breast tumours.
MacCallum J; Cummings J; Dixon JM; Miller WR
Br J Cancer; 2000 May; 82(10):1629-35. PubMed ID: 10817496
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a quantitative assay for the analysis of tamoxifen with its four main metabolites and the flavonoids daidzein, genistein and glycitein in human serum using liquid chromatography coupled with tandem mass spectrometry.
Teunissen SF; Rosing H; Koornstra RH; Linn SC; Schellens JH; Schinkel AH; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Aug; 877(24):2519-29. PubMed ID: 19589736
[TBL] [Abstract][Full Text] [Related]
15. Quantitative measurement of 4-hydroxy tamoxifen in human plasma and mammary tumours by combined gas chromatography/negative chemical ionization mass spectrometry.
Girault J; Istin B; Fourtillan JB
Biol Mass Spectrom; 1993 Jul; 22(7):395-402. PubMed ID: 8357855
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of tamoxifen and metabolites by LC-MS/MS and HPLC methods.
Heath DD; Flat SW; Wu AH; Pruitt MA; Rock CL
Br J Biomed Sci; 2014; 71(1):33-9. PubMed ID: 24693573
[TBL] [Abstract][Full Text] [Related]
17. Bioanalytical methods for determination of tamoxifen and its phase I metabolites: a review.
Teunissen SF; Rosing H; Schinkel AH; Schellens JH; Beijnen JH
Anal Chim Acta; 2010 Dec; 683(1):21-37. PubMed ID: 21094378
[TBL] [Abstract][Full Text] [Related]
18. Role and pharmacologic significance of cytochrome P-450 2D6 in oxidative metabolism of toremifene and tamoxifen.
Kim J; Coss CC; Barrett CM; Mohler ML; Bohl CE; Li CM; He Y; Veverka KA; Dalton JT
Int J Cancer; 2013 Mar; 132(6):1475-85. PubMed ID: 22915089
[TBL] [Abstract][Full Text] [Related]
19. Solid-phase extraction and high-performance liquid chromatographic determination of tamoxifen and its major metabolites in plasma.
MacCallum J; Cummings J; Dixon JM; Miller WR
J Chromatogr B Biomed Appl; 1996 Apr; 678(2):317-23. PubMed ID: 8738037
[TBL] [Abstract][Full Text] [Related]
20. Structure elucidation of three isomeric metabolites of SYN-2836, a novel antifungal agent, in dogs via liquid chromatography/mass spectrometry and liquid chromatography/tandem mass spectrometry methodologies.
Bu HZ; Poglod M; Micetich RG; Khan JK
J Mass Spectrom; 1999 Nov; 34(11):1185-94. PubMed ID: 10548812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
